A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer

Table 2

Prospective study characteristics for comprehensive treatment of limited metastatic NSCLC with hypofractionated RT.

Study group	Inclusion	Systemic therapy	Radiotherapy	Outcome
NCCTG [30]	1–3 metastatic sites	Nonstandardized	60 Gy (2 Gy fx); 45 Gy (3 Gy fx)	Closed due to poor accrual
University of Chicago [31]	1–5 metastatic sites	Cisplatin; docetaxel	50 Gy (5 Gy fx); 60 Gy (2 Gy fx) if Combined with CT	Closed due to poor accrual
Wake Forest University [32]	Limited metastatic NSCLC	Non-standardized	HIGRT or; conventional RT	Open to accrual